Amphastar Pharmaceuticals, Inc. AMPH

26.13 (0.14) (0.53%) as of 25 Sep
Market cap
$1.1B
P/E
15.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
12.75 11.29 21.93 15.08 17.92 502.75 18.55 0.00 249.61 77.08
P/S ratio
1.74 2.46 4.67 2.74 2.54 2.70 2.81 3.13 3.68 3.29
P/FCF ratio
10.53 10.44 20.71 20.93 15.81 40.67 16,183.62 0.00 144.66 48.87
P/Operating CF
38.09 61.95 125.98 89.92 27.51 56.00 160.35 97.01 90.51 59.93
P/B ratio
1.59 2.46 4.70 2.59 2.50 2.11 2.12 2.53 2.65 2.55
Price to Tangible BV
5.62 12.70 115.07 2.79 2.74 2.32 2.35 2.87 3.06 3.01
EV/Sales
2.19 2.97 5.18 2.54 2.40 2.52 2.68 2.99 3.58 3.15
EV/EBITDA
7.87 8.23 13.54 9.54 11.25 27.18 47.81 111.51 59.05 26.71
EV/Operating CF
10.10 10.20 18.19 14.21 10.72 15.41 20.69 23.05 21.90 20.82
EV/FCF
13.27 12.64 22.99 19.37 14.93 37.95 15,426.84 (221.59) 140.53 46.74
Quick Ratio
2.82 2.08 1.66 2.82 2.10 1.57 1.50 1.36 1.70 1.67
Current Ratio
4.02 3.07 2.17 3.99 3.06 2.49 2.84 2.06 2.79 3.04
Net Debt/EBITDA
1.62 1.43 1.34 (0.77) (0.67) (1.95) (2.35) (5.46) (1.73) (1.22)
Debt/Assets
37.46% 38.15% 39.00% 10.23% 11.46% 7.36% 8.03% 9.78% 10.45% 8.82%
Debt/Equity
0.77 0.82 0.92 0.14 0.17 0.10 0.11 0.14 0.14 0.11
Asset Turnover
0.45 0.47 0.57 0.71 0.67 0.57 0.59 0.61 0.55 0.62
Operating CF/Net income
1.59 1.34 1.33 0.98 1.58 40.82 0.85 (6.66) 10.75 3.93
Capex/Depreciation
(0.62) (0.70) (0.77) (0.94) (1.17) (1.57) (2.29) (2.55) (2.09) (1.46)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
12.90% 23.26% 23.55% 18.76% 13.89% 0.32% 12.36% (1.64%) 1.10% 3.14%
ROA
6.12% 10.32% 12.20% 12.93% 9.54% 0.23% 8.89% (1.19%) 0.83% 2.40%
ROIC
7.88% 11.57% 12.69% 15.76% 11.39% 1.78% (0.01%) (1.68%) (0.26%) 3.28%
Return on Tangible Assets
12.44% 24.26% 25.15% 17.52% 13.55% 0.33% 12.26% (1.77%) 1.21% 3.55%
Average Days of Receivables
81.49 68.83 65.40 65.08 65.81 69.27 51.73 64.67 63.88 38.33
Research and Development Expense of Revenue
11.92% 10.10% 11.44% 14.98% 13.92% 19.22% 21.36% 19.54% 18.11% 16.27%
Selling, General and Administrative Expense of Revenue
18.03% 12.91% 12.48% 13.35% 15.74% 18.62% 19.58% 19.70% 21.20% 18.54%
Intangible Assets out of Total Assets
0.35 0.37 0.41 0.05 0.06 0.06 0.07 0.08 0.10 0.12
Share Based Compensation of Revenue
3.79% 3.33% 3.14% 3.58% 4.27% 5.86% 5.37% 5.66% 7.11% 5.93%
Graham Net Nets
(0.16) (0.17) (0.13) 0.12 0.08 0.10 0.11 0.08 0.08 0.10
Graham Number
28.24 33.46 29.10 21.40 16.52 2.93 14.59 0.00 3.54 6.26
Earnings Yield
7.84% 8.86% 4.56% 6.63% 5.58% 0.20% 5.39% (0.65%) 0.40% 1.30%
Free Cash Flow Yield
9.49% 9.58% 4.83% 4.78% 6.33% 2.46% 0.01% (0.43%) 0.69% 2.05%
Revenue per Share
15.40 15.11 13.35 10.28 9.16 7.44 6.86 6.35 5.21 5.62
Operating CF per Share
3.34 4.41 3.80 1.84 2.05 1.22 0.89 0.82 0.85 0.85
Capex per Share
(0.79) (0.85) (0.79) (0.49) (0.57) (0.72) (0.88) (0.91) (0.72) (0.47)
Free Cash Flow per Share
2.55 3.56 3.01 1.35 1.48 0.50 0.00 (0.09) 0.13 0.38
Cash per Share
6.10 4.63 5.37 3.67 2.91 2.33 1.91 2.01 1.57 1.64
Shareholders Equity per Share
16.88 15.12 13.25 10.89 9.33 9.54 9.10 7.85 7.24 7.26
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
16.88 15.12 13.25 10.89 9.33 9.54 9.10 7.85 7.24 7.26
Free Cash Flow
118.98 172.35 145.34 65.57 70.54 23.41 0.21 (3.97) 6.11 17.18
Working Capital
477.86 360.31 264.19 283.46 214.31 167.48 165.23 113.51 120.59 123.48
Capital Expenditures
(37.13) (41.04) (38.17) (23.61) (27.46) (33.85) (41.55) (42.16) (33.10) (21.38)
Net Current Asset Value
(204.48) (311.10) (383.89) 164.99 92.11 97.17 95.80 71.14 70.44 85.61
EV/EBIT
11.23 10.59 16.94 11.78 15.03 80.58 0.00 0.00 0.00 52.22
Capex to Sales
0.05 0.06 0.06 0.05 0.06 0.10 0.13 0.14 0.14 0.08
Net Profit Margin
13.63% 21.79% 21.34% 18.31% 14.19% 0.40% 15.18% (1.95%) 1.52% 3.85%
Price to Operating Income
8.92 8.75 15.26 12.74 15.92 86.36 0.00 0.00 0.00 54.59
Other line items
Depreciation/Fixed assets
0.19 0.20 0.17 0.11 0.10 0.08 0.08 0.08 0.09 0.10
Cash ROIC
(9.17%) (5.39%) (6.67%) (19.05%) (22.11%) (33.53%) (34.05%) (33.91%) (31.18%) (25.92%)
Accounts Receivable Turnover
4.82 5.77 6.30 5.94 6.02 6.24 6.59 6.25 6.98 8.47
Accounts Payable Turnover
2.38 2.86 3.30 2.88 2.57 2.39 2.32 2.59 2.85 4.92
Inventory Turnover
2.20 2.76 2.80 2.55 2.51 1.99 2.12 2.82 2.09 2.01
Average Days of Payables
148.83 160.08 116.20 122.93 137.31 168.80 147.68 170.01 140.36 114.95
Days of Inventory on Hand
177.46 156.70 131.72 151.16 142.31 171.15 211.79 134.82 155.13 192.82
Average Receivables
149.38 126.75 102.22 83.95 72.66 56.04 48.95 47.12 34.42 30.14
Average Payables
152.70 125.21 88.80 86.89 92.52 86.28 82.23 72.49 52.55 30.71
Average Inventory
165.32 129.79 104.71 98.20 94.82 103.67 89.91 66.47 71.68 75.21
Average Assets
1,603.38 1,545.19 1,127.45 706.76 651.38 609.10 550.27 482.32 439.41 408.94
Average Common Equity
760.55 685.86 584.04 487.09 447.12 438.13 395.94 349.05 331.50 312.38

Fold the line items

Columns are period end dates